MedTrace Logo

OptiMEDs Pilot Study

NCT04142645 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2021-11-29

No results posted yet for this study

Summary

Pilot study of the OptiMEDs intervention: a complex intervention for multidisciplinary medication review (including nurses, pharmacists, and physicians) in nursing homes (NH), with ICT-support for the evaluation of the appropriateness of prescribing and for side-effect monitoring.

Conditions

  • Medication Review
  • Nursing Home Resident
  • Nursing Home

Interventions

DEVICE

OptiMEDs

The OptiMEDs intervention is a multi-faceted intervention combining: 1. an ICT platform: * automatic and secure capture of individual prescribing information from the electronic medication administration records in the nursing home * a tool for structured nurse observations of side effects, derived from the existing Pharmanurse application (20) (used to list potential medication side effects, based on the individual medication chart of the nursing home residents) to support monitoring of medication safety by nurses. * an electronic decision support tool for the appraisal of potentially inappropriate medication (explicit criteria of misuse and underused of medication, based on existing lists of explicit criteria (PIMs)), use of medication with anticholinergic properties and medication inappropriate in view of the limited life expectancy. 2. a multidisciplinary medication review with the input of GPs, trained community-pharmacists and nurses.

Sponsors & Collaborators

  • Universiteit Antwerpen

    collaborator OTHER

  • University Ghent

    lead OTHER

Principal Investigators

  • Thierry Christiaens, PhD, MD · Faculty of Medicine and Health Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-09
Primary Completion
2020-03-20
Completion
2020-03-20

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04142645 on ClinicalTrials.gov